|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating expenses: | |||||
| Research and development expenses | |||||
| Marketing expenses | |||||
| General and administrative expenses | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Other income (expense): | |||||
| Other (income) expense | |||||
| Finance income, net | |||||
| Change in fair value of derivative liability | |||||
| Loss on equity issuance | |||||
| Finance expense, net | |||||
| Total other income | |||||
| Net loss | |||||
| Other comprehensive loss: | |||||
| Foreign currency translation adjustment | |||||
| Comprehensive loss | |||||
| Basic loss per share | |||||
| Diluted loss per share | |||||
| Weighted average number of common stock outstanding used in computing basic net loss per share | |||||
| Weighted average number of common stock outstanding used in computing diluted net loss per share | |||||
Loading...